NewsRoom Articles - Page 185 of 202

ThursdaySep 24, 2020 1:45 pm

Scientists Develop Human Retinas in a Dish

A team of scientists from the Institute for Molecular and Clinical Ophthalmology Basel (“IOB”) that was led by Botond Roska, in collaboration with the Novartis Institutes for BioMedical Research, have created indistinguishable replicas of human retinas in culture. These will be used to help find the specific cell types that are affected by genetic eye ailments. This project, which took 6 years, will significantly speed up the process of developing new therapies for eye ailments. The paper’s principal author, who is also a senior researcher in the IOB Human Retinal Circuit Group, Cameron Cowan, says that the research sheds light…

WednesdaySep 23, 2020 3:15 pm

Harvard Professor Launching Nasal Hygiene Mist Developed to Reduce Coronavirus Transmission

David A. Edwards, a professor of Biomedical Engineering at Harvard, is set to launch a new product that he developed, this fall. He claims that the product reduces almost 100% of particles that are present in exhaled air. This will help reduce the transmission of SARS-CoV-2 both out of and into the lungs while breathing. This would mean that the risk of contracting COVID-19 would significantly decrease, especially for frontline workers, when it is used in combination with other Personal Protective Equipment like face masks. The product is known as FEND and has been produced by Sensory Cloud, a tech…

WednesdaySep 23, 2020 2:00 pm

Federal Government Announces COVID-19 Vaccine Distribution Plan

On Wednesday of last week, the Trump administration announced their plan to distribute a coronavirus vaccine, free of charge, once it has been approved for use. The plan focuses on targeted groups then expands as the supply of the vaccine grows. The government released a phased distribution using a contract that was awarded to McKesson earlier in August of this year. The first recipients of the vaccine could be: Healthcare workers who are likely to be exposed to the virus or those that treat and care for people who have COVID-19. Other essential workers Individuals who are at an increased…

WednesdaySep 23, 2020 12:54 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Mines Investment-building Opportunity for Brain Tumor-Targeting Drug Candidate at Annual Conference

CNS Pharmaceuticals is a clinical-stage biotechnology company developing therapies to combat aggressive cancers of the brain and central nervous system The company will be applying for approval to launch Phase II trials in the first quarter of 2021 for its leading drug candidate, Berubicin, which targets glioblastoma multiforme (“GBM”) brain cancer CNS Pharmaceuticals CEO addressed the company’s achievements and its vision for Berubicin development during the recent 22nd annual Global Investment Conference sponsored by H.C. Wainwright & Co. C. Wainwright is a full-service investment bank focused on capital markets and equity research in market sectors that hinge on industries encompassing…

TuesdaySep 22, 2020 3:00 pm

EU Announces Plans to Form Biomedical Research Agency

Ursula von der Leyen, the European Commission president, announced plans for the European Union (“EU”) to play a much greater role in the health sector. The EU plans to form a new agency for biomedical research, which will be modeled on the United States Biomedical Advanced Research and Development Authority (“BARDA”). The agency will help reinforce the European Center for Disease prevention and Control and the European Medicines Agency. The EU BARDA will also support the European Union’s readiness and capacity to counter cross-border emergencies and threats, whether they were deliberate or natural. The EU BARDA is seen as a…

TuesdaySep 22, 2020 1:00 pm

Infectious Disease Expert Provides Overview of Biomedical Research Process

Since the COVID-19 crisis was declared a pandemic by the World Health Organization, it has claimed the lives of more than 958,000 people worldwide. The disease was caused by the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Across the globe, researchers, public health experts and clinicians have dedicated their energy, time and expertise to the coronavirus pandemic in an effort to rid society of this disease and restore a sense of normalcy from the warped times we now live in. In the past 7 months, scientists have discovered and learnt a lot about the virus and the disease it…

MondaySep 21, 2020 3:25 pm

Could Your Hormones Be Making You Sick?

A recent study by researchers from Michigan State University shows that various differences in biological sex can determine long-term disease patterns, which may link specific hormones that were present before and after birth with a body’s immune responses as well as its long-term immunological disease growth. The study, which was published in the Proceedings of National Academy of Sciences, discussed various reasons why females are more at risk for various common diseases that involve the immune system such as migraines, allergies, irritable bowel syndrome and asthma. The study findings by Emily Mackey, Adam Moeser and Cynthia Jordan usher in new…

MondaySep 21, 2020 2:10 pm

KBL Merger Corp. IV (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp.

KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b/3, helping mitigate the risks involved with its drug development The merger with 180 Life Sciences will enable KBL Merger Corp. IV to enter a market expected to double in size by 2027 180 Life Sciences is growing its patent portfolio through several preclinical studies beginning in two additional areas of inflammatory novel drug studies KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp.…

MondaySep 21, 2020 11:15 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s CIO Discusses Curing Cancer with AI on DojoLIVE! Interview

POAI subsidiary Helomics exec discusses the company’s quest to fight cancer Helomics tapping into the fast growing, billion-dollar AI in drug discovery market Pittsburgh-based company has been building foundational groundwork in cancer drug response profiling for two decades Helomics harnesses rich historic tumor data with the power of AI to test living tumor tissues Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its executives, Helomics CIO Mark Collins, PhD, recently appeared on DojoLIVE! (https://ibn.fm/hSAn4). Helomics, a POAI subsidiary, applies artificial intelligence to its rich data gathered…

MondaySep 21, 2020 11:00 am

Important Coronavirus Pandemic Lessons for the Diagnostics Industry

As we all know by now, the best way to help stop the spread of coronavirus is getting a coronavirus test done and wearing a mask, of course. A test reveals whether a person is negative or positive. A negative test result means an individual does not have the virus while a positive result means that one does have the virus. As we have seen, a positive rest result warrants quarantine for a 2-week period during which an individual is observed or treated, depending on the severity of their symptoms. Around the world, 200 million tests have been performed. However,…